Methods and compositions using selective cytokine inhibitorly drugs for treatment and management of cancers and other diseases

Details for Australian Patent Application No. 2003234624 (hide)

Owner Celgene Corporation

Inventors Zeldis, Jerome B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003234624

PCT Number PCT/US03/15468

PCT Pub. Number WO2003/097040

Priority 60/380,842 17.05.02 US; 60/424,601 06.11.02 US

Filing date 16 May 2003

Wipo publication date 2 December 2003

Acceptance publication date 29 January 2009

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/00 (2006.01)

A61K 31/198 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4035 (2006.01)

A61K 31/425 (2006.01) - Thiazoles

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/454 (2006.01)

A61K 31/515 (2006.01)

A61K 31/573 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/14 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 11/16 (2006.01) Drugs for disorders of the respiratory system

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/06 Drugs for dermatological disorders

Event Publications

28 August 2003 Complete Application Filed

  Priority application(s): 60/380,842 17.05.02 US; 60/424,601 06.11.02 US

29 January 2004 Application Open to Public Inspection

  Published as AU-B-2003234624

29 January 2009 Application Accepted

  Published as AU-B-2003234624

12 March 2009 Corrigenda

  Applications Accepted - Name Index Under the name Celgene Corporation, Application No. 2003234624, under INID(54), correct the title to Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases

28 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003234625-Methods and copositions for the treatment of ischemic reperfusion

2003234623-USE OF GASTRIN RELEASING PEPTIDE (GRP) AND ITS RECEPTOR IN CANCER SCREENING